Weight loss drugs like Ozempic and Wegovy are doing something doctors didn’t fully expect: changing how skin diseases behave, for better and for worse.
Story Snapshot
- A Fort Worth dermatologist says GLP-1 drugs may improve inflammatory skin conditions like psoriasis and hidradenitis suppurativa.
- The same drug class is linked to skin side effects, including injection-site rashes, thinning hair, and sagging skin.
- Nearly 39 percent of GLP-1 users in one study reported some kind of skin change.
- Researchers say the science on skin benefits is still young, built on small studies and case reports.
A Fort Worth Doctor Sees An Unexpected Pattern
Dr. Katherine Durham, a dermatologist with U.S. Dermatology Partners in Fort Worth, told NBC 5 Dallas-Fort Worth she and her colleagues have noticed something. Patients on GLP-1 drugs for diabetes or weight loss sometimes see their psoriasis or hidradenitis suppurativa calm down. “In large part, it is due to the weight loss,” Durham said, pointing to less strain on the body’s inflammatory systems.
Both conditions Durham mentioned are chronic and painful. Psoriasis causes thick, scaly patches. Hidradenitis suppurativa creates deep, recurring lumps under the skin, often in the armpits and groin. Doctors have long known that carrying extra weight makes both conditions worse. Shedding pounds through GLP-1 drugs appears to ease that burden for some patients, according to Durham’s clinical observations.
The Skin Damage Nobody Warned You About
The same medications causing rapid, dramatic weight loss are also reshaping faces and bodies in ways patients did not sign up for. Plastic surgeons across North Texas report a wave of new patients dealing with loose, sagging skin after quick weight drops. One study found 38.7 percent of GLP-1 users reported some type of skin change during treatment.
The American Academy of Dermatology lists a long menu of possible side effects. Patients have reported injection-site itching and swelling, thinning hair, premature skin aging, excessive sweating, and dry skin caused by hormone shifts and reduced water intake. Rapid weight loss can also cause brittle nails and loose, hanging skin that some patients now seek surgery to correct.
Why This Is Called A Paradox
Medical researchers have started calling this split effect a paradox. The same drug class that may calm inflammatory skin disease can also trigger rare but serious immune reactions, including a blistering condition called bullous pemphigoid, along with panniculitis and vasculitis. A broader review found dermatologic side effects made up an estimated 6.08 percent of all adverse events reported to federal regulators through 2024.
Most of these reactions are mild and go away once the body adjusts, according to research reviewing dozens of studies. Still, the range of possible outcomes, from clearer skin to blistering rashes, shows why doctors are treating this class of drugs with both enthusiasm and caution. The science is moving fast, but the full picture is not finished yet.
The Evidence Is Real, But Still Thin
A 2026 review found the benefit data limited by small patient samples, mixed study designs, and the fact that many patients were already being treated for diabetes or obesity at the same time. That overlap makes it hard to know exactly how much credit belongs to the GLP-1 drug itself versus the weight loss it causes. Researchers say larger, more focused studies are needed before dermatologists can confidently prescribe these drugs for skin disease alone.
One study found real-world benefits for hidradenitis suppurativa sufferers using large claims and health record data, a step up from smaller case reports. Another study identified a genetic link between GLP-1 receptor activity and hair follicle biology, adding a possible explanation for why some patients lose hair while others see skin improve. The research keeps stacking up, but conclusions remain careful and qualified.
A new study in the Journal of Investigative Dermatology found the first genetic link between GLP-1 receptor activity and male pattern hair loss.
NYU Langone Health researchers analyzed data from 205,327 men.
Those predisposed to androgenetic alopecia had a 7% added risk with… pic.twitter.com/CTksFWG4SB
— karmactive (@karmactivealive) September 23, 2026
What This Means For Patients Weighing Their Options
Anyone considering a GLP-1 drug for weight loss or diabetes should factor skin health into that decision, not just the number on the scale. Durham and other dermatologists recommend patients talk openly with both their prescribing doctor and a skin specialist about existing conditions like psoriasis before starting treatment. The drugs may bring a welcome side benefit, or an unwelcome side effect. Knowing which is more likely for your own body starts with an honest conversation, not a guess.
Sources:
youtube.com, nbcdfw.com, ground.news, aad.org, resources.aad.org, nyulangone.org, forefrontdermatology.com, pubmed.ncbi.nlm.nih.gov
